15 November 2024
Hellenic Dynamics
plc
("Hellenic Dynamics" or the
"Company")
Update on €1 million
loan
London, 15 November 2024, -
Hellenic Dynamics plc (LSE: HELD), a medical cannabis cultivator
focused on producing medical cannabis flowers for global markets
announces that further to the Company's announcement of 7 October
2024, which provided an update on the receipt of
the €1 million loan originally announced on 22
April 2024, the Company confirms that,
despite continued reassurances from the
lender, the loan has not been received and
the directors of the Company have no certainty that the loan will
be received, and if received on the timing of such receipt. As
such, the Company is now exploring alternative financing options to
meet its working capital needs effectively.
This announcement contains inside
information for the purposes of article 7 of the Market Abuse
Regulation (EU) 596/2014 as amended by regulation 11 of the Market
Abuse (Amendment) (EU Exit) Regulations 2019/310. With the
publication of this announcement, this information is now
considered to be in the public domain.
The Directors of the Company take
responsibility for this announcement.
Enquires:
Hellenic Dynamics
Plc
+44 (0)20 3818
7850
Davinder Rai
info@hellenicdynamics.com
Cairn Financial Advisers
LLP
Emily Staples / Jo Turner
+44 (0)20 7213 0880
Peterhouse Capital -
Brokers
Lucy Williams / Charles Goodfellow
+44 (0)20 7469
0930
Caution regarding forward looking
statements
Certain
statements in this announcement, are, or may be deemed to be,
forward looking statements. Forward looking statements are
identified by their use of terms and phrases such as ''believe'',
''could'', "should" ''envisage'', ''estimate'', ''intend'',
''may'', ''plan'', ''potentially'', "expect", ''will'' or the
negative of those, variations or comparable expressions, including
references to assumptions. These forward-looking statements are not
based on historical facts but rather on the Directors' current
expectations and assumptions regarding the Company's future growth,
results of operations, performance, future capital and other
expenditures (including the amount, nature and sources of funding
thereof), competitive advantages, business prospects and
opportunities. Such forward looking statements reflect the
Directors' current beliefs and assumptions and are based on
information currently available to the Directors.
